IMMUNE-RELATED ADVERSE EVENT
Clinical trials for IMMUNE-RELATED ADVERSE EVENT explained in plain language.
Never miss a new study
Get alerted when new IMMUNE-RELATED ADVERSE EVENT trials appear
Sign up with your email to follow new studies for IMMUNE-RELATED ADVERSE EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a simple asthma drug prevent a dangerous immunotherapy side effect?
Disease control Recruiting nowThis study tests whether a year of inhaled budesonide (a common asthma medication) can prevent lung inflammation from coming back in cancer patients who had a serious immune reaction to immunotherapy. About 94 adults with solid tumors who recently recovered from checkpoint inhibi…
Matched conditions: IMMUNE-RELATED ADVERSE EVENT
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated May 26, 2026 05:56 UTC
-
New hope for cancer patients: drug may reduce steroid dependency for arthritis side effect
Symptom relief Recruiting nowThis study tests whether giving adalimumab early can reduce the need for steroids in people who develop inflammatory arthritis as a side effect of immune checkpoint inhibitor cancer therapy. About 30 adults with new arthritis from their cancer treatment will be randomly assigned …
Matched conditions: IMMUNE-RELATED ADVERSE EVENT
Phase: PHASE2 • Sponsor: Tom Appleton • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC